A recent study published in The Lancet Respiratory Medicine revealed an increase in lung cancer cases among non-smokers, ...

In a world where we’ve grown accustomed to hearing about the dangers of smoking, another unexpected health risk is beginning to rise. It’s a threat that doesn’t discriminate between smokers and ...

Lung cancer cases among non-smokers are rising, with air pollution potentially contributing to the increase, according to a new study published in The Lancet Respiratory Medicine journal on World ...

Lung cancer has long been associated with smoking, but a mysterious rise in cases among non-smokers is challenging that ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

Lung cancer cases among non-smokers are rising, driven by factors like air pollution, second-hand smoke, and genetic ...

The firms will evaluate two adjuvant treatment options, Datroway with rilvegostomig or rilvegostomig monotherapy, against standard-of-care treatment.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Daniel Rubin, PharmD, BCOP, discussed a study showing how a clinical decision support tool can improve the documentation of biomarker results in cancer care.